BCR-ABL1 testing is used to:Help diagnose chronic myelogenous leukemia (CML) or a type of acute lymphoblastic leukemia (ALL)Monitor treatmentMonitor for recurrenceDetect resistance to therapyBCR-ABL1 refers to a gene sequence found in an abnormal chromosome 22 of some people with certain forms of leukemia. Testing is ordered to detect the Philadelphia (Ph) chromosome and BCR-ABL1 gene sequence. It is used to help diagnose CML and specific types of ALL and, rarely, acute myeloid leukemia (AML) in which the BCR-ABL1 gene sequence is present (BCR-ABL1-positive). It is also used to monitor response to treatment and to monitor for disease recurrence. At diagnosis, 9-95% of cases of CML are BCR-ABL1-positive. About one in four adults with ALL have the sequence.
Sample Type - Bone Marrow
Reporting Time - Please Call Customer care
Prerequisites - No special preparation required
Price - ₹5010/-
Add to cart Go Home